Gaviscon



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 73.3%
Gastrooesophageal Reflux Disease 20.0%
Dyspepsia 6.7%
Anaphylactic Reaction 14.8%
Constipation 7.4%
Drug Ineffective 7.4%
Reaction To Drug Excipients 7.4%
Stomach Discomfort 7.4%
Cardiospasm 3.7%
Dental Caries 3.7%
Gastrooesophageal Reflux Disease 3.7%
Hallucination 3.7%
Hepatic Enzyme Increased 3.7%
Liver Disorder 3.7%
Melaena 3.7%
Nausea 3.7%
Palpitations 3.7%
Paraesthesia Oral 3.7%
Pneumonia Aspiration 3.7%
Rectal Haemorrhage 3.7%
Swollen Tongue 3.7%
Urine Analysis Abnormal 3.7%
Urticaria 3.7%
Secondary
Product Used For Unknown Indication 35.0%
Drug Use For Unknown Indication 17.5%
Migraine 9.4%
Osteoarthritis 7.3%
Asthma 6.3%
Ill-defined Disorder 4.5%
Chronic Obstructive Pulmonary Disease 3.3%
Epilepsy 2.7%
Drug Exposure During Pregnancy 2.6%
Deep Vein Thrombosis 2.5%
Hypothyroidism 2.5%
Dyspnoea 1.2%
Gastrooesophageal Reflux Disease 0.9%
Fluid Replacement 0.7%
Colon Cancer 0.6%
Crohn's Disease 0.6%
Gastritis 0.6%
Anxiety 0.5%
Bronchitis 0.5%
Depression 0.5%
Dyspnoea 15.8%
Mesothelioma 12.3%
Drug Interaction 7.0%
Haemorrhage 7.0%
Hypertriglyceridaemia 6.1%
Acute Respiratory Distress Syndrome 5.3%
Cerebrovascular Accident 5.3%
Necrotising Colitis 5.3%
Respiratory Failure 5.3%
Peritonitis 4.4%
Death 3.5%
Renal Failure Acute 3.5%
Epilepsy 2.6%
Hyponatraemia 2.6%
Neutropenia 2.6%
Pulmonary Fibrosis 2.6%
Talipes 2.6%
Ventricular Septal Defect 2.6%
Breast Lump Removal 1.8%
Cardiospasm 1.8%
Concomitant
Product Used For Unknown Indication 26.6%
Drug Use For Unknown Indication 25.4%
Gastrooesophageal Reflux Disease 7.9%
Hypertension 5.3%
Prophylaxis 5.0%
Pain 4.3%
Dyspepsia 3.3%
Depression 2.7%
Asthma 2.4%
Diabetes Mellitus 2.2%
Constipation 2.1%
Rheumatoid Arthritis 1.9%
Multiple Myeloma 1.5%
Anxiety 1.4%
Insomnia 1.4%
Hiv Infection 1.4%
Epilepsy 1.3%
Nausea 1.3%
Osteoporosis 1.3%
Lower Respiratory Tract Infection 1.2%
Vomiting 18.1%
Renal Failure Acute 7.0%
Thrombocytopenia 6.7%
Tremor 5.7%
Weight Decreased 5.7%
Weight Increased 5.4%
Cytolytic Hepatitis 4.7%
Death 4.7%
Hypoglycaemia 4.7%
Dyspnoea 3.9%
Malaise 3.9%
Electrocardiogram Qt Prolonged 3.6%
Delirium 3.4%
Nausea 3.4%
Pulmonary Embolism 3.4%
Somnolence 3.4%
Hyponatraemia 3.1%
Neutropenia 3.1%
Pneumonia 3.1%
Premature Baby 3.1%
Interacting
Acute Sinusitis 50.0%
Flatulence 50.0%
Drug Interaction 33.3%
Faeces Discoloured 33.3%
Nausea 33.3%